Skip to main content

🛒🛒 Amazon extends warehousing facility to outside sellers; Garena relaunches its battle royale game in India

Amazon has also signed a memorandum of understanding with India Post to create a cross-border logistics solution that will expand the opportunity of global selling for businesses.
Daily Top 5

A closer look at today's biggest tech and startup stories and why they matter

Good evening Reader,

On Thursday, Amazon launched Multi Channel Fulfillment for sellers, even those not on its platform, along with striking deals with India Post and Indian Railways. This and more in today's ETtech Top 5.

Also in this letter:
■ Generative AI moving tech outside IT departments: Google Cloud CEO
■ SoftBank likely to fully exit Zomato in coming months
■ Lessons from Chandrayaan-3 may land in IIM classrooms

Amazon to offer fulfillment infrastructure to sellers outside its platform

Amazon
(From left) Amazon SVP international consumer, Russell Grandinetti and Amazon SVP India and emerging markets Amit Agarwal

Amazon on Thursday announced the launch of Multi Channel Fulfillment (MCF), which will enable sellers to run their online businesses by accessing its infrastructure, even if they are not on the ecommerce platform.

Details: With this, direct to consumer (D2C) sellers can use Amazon's logistics and supply chain capabilities to pick, pack and ship to customers from their inventory in Amazon fulfillment centres via multiple sales channels, including their own websites.

Logistics deal with India Post, railway services: Amazon has also signed a memorandum of understanding with India Post to create a cross-border logistics solution that will expand the opportunity of global selling for businesses. The company is also partnering with the Indian Railways' Dedicated Freight Corridor Corporation of India to make use of freight corridors.

Also read | Amazon shrugs off ups and downs in its decade-long India journey

AI-based virtual assistant: The company also rolled out Amazon Sah-AI, a generative artificial intelligence-driven virtual assistant that will help sellers on Amazon clarify their queries, list products, generate product attributes, analyse trends in their sales, and so on.

Also read | Amazon set to cross $8 billion in cumulative exports from India in 2023

Uptick in sales: Talking about the India ecommerce market, Manish Tiwary, vice president and country manager, Amazon India consumer business, said the company has seen a "clear improvement" over the last two to three months. "We had the Prime Day in July, and it was the first time the response was well ahead of our plan. We had a good situation where a lot of our sellers sold out. On the output side…14-15% more Prime members bought (during Prime Day)," Tiwary said.
Liked reading? Share this story
whatuphate ithate it

Wealth Edition
Garena's Free Fire returns to India a year after it was blocked

Free fire India

Game developer Garena on Thursday announced the relaunch of the Indian version of its popular battle royale game, Free Fire, over a year and a half after it was blocked by the government.

With Indian tadka: "Garena is employing servers run by Yotta, a unit of the Hiranandani group, to provide cloud hosting and data storage services," the firm said in a statement.

In February last year, the government banned over 50 apps, including Free Fire, over concerns that Indian user data was being sent to servers in China. The Indian government did not specify why Free Fire in particular was blocked.

BGMI relaunch: The Sea Ltd-owned game has been relaunched just a few months after the most popular game in the Indian esports ecosystem, Krafton's Battlegrounds Mobile India (BGMI), returned from a government block on a three-month trial basis late in May. BGMI had roughly 100 million registered users in the country pre-block.
Liked reading? Share this story
whatuphate ithate it

Subscribe to our daily newsletter ETtech Morning Dispatch for the latest insights from the world of technology and startups.

Subscribe
Generative AI moving tech outside IT departments: Google Cloud CEO

Thomas Kurian
Google Cloud CEO Thomas Kurian

Generative artificial intelligence (AI) is making functions such as marketing and human resources adopt technology, which, in turn, is expanding the overall addressable market, according to Google Cloud chief executive Thomas Kurian.

Quote, unquote: "Generative AI is moving technology out of the IT department into many other functions in companies. Before generative AI, the marketing, HR, procurement, supply chain departments—none were talking to us. In this conference alone, a lot of attendees are not necessarily engineers but people from different business lines," said Kurian, during a media roundtable at the Google Cloud Next 2023 event.

The executive said the company is making AI for all—through a chat interface—similar to how it made the internet for all through its search engine in the late 1990s.

IBM CEO on AI: A week ago, global technology giant IBM's CEO Arvind Krishna said the company was internally using AI to drive productivity in lower-order cognitive tasks. He added that Big Blue has been deploying the technology in 90% of the "mundane" tasks under the human resources department, such as promoting and assessing candidates.

Google brings generative AI to Search in India: Google is rolling out its Search Generative Experience (SGE), which offers generative AI-powered responses to search-engine queries, for users to experiment with and share feedback under the company's Search Labs programme. SGE is available in English and Hindi, and includes India-focused features such as language toggle, text-to-speech, and voice input in a conversational mode.
Liked reading? Share this story
whatuphate ithate it

SoftBank likely to fully exit Zomato in coming months

SoftBank Zomato exit

Japanese investment giant SoftBank, which has sold nearly 10 crore shares in online food delivery platform Zomato, amounting to 1.17% of the company's equity, is planning to fully exit the online food-delivery platform in the next few months. According to sources, SoftBank still has a stake of around 2.18% in Zomato, which it is likely to sell via block deals.

Background: On Wednesday, around 10 crore shares of Zomato changed hands at a total deal value of around Rs 947 crore. SoftBank's SVF Growth Fund was the likely seller in this mega transaction. SVF Growth (Singapore) Pte. Ltd. had a 3.35% stake in Zomato, totalling around 28 crore shares.

Following the Tiger trail: The fresh block sale came after another foreign institutional investor, Tiger Global Management, offloaded its entire shareholding of 1.44% in Zomato earlier this week. The deal earned Tiger Global a total of Rs 1,123 crore. The New York-based fund sold around 12.34 crore shares or 1.44% in Zomato at an average price of Rs 91.01 per share.
Liked reading? Share this story
whatuphate ithate it

Lessons from Chandrayaan-3 may land in IIM classrooms

Chandrayaan

Chandrayaan-3's historic moon landing is set to provide plenty of food for thought for budding managers at the Indian Institutes of Management (IIMs).

The plan: The mission, executed on a mere Rs 615 crore budget, is a case study in frugal innovation. Management students can study the project to imbibe lessons in strategy, collaboration, innovation, cost control and optimisation of resources, how leaders process failure and move on, etc.

Chandrayaan GFX

Case study in works: At IIM Sirmaur, faculty members are working on a case study on the topic, said director Prafulla Agnihotri. "It's an amazing example of how an organisation should learn from its experiences, improvise its efforts, and achieve a near-impossible goal."

This phenomenon will have implications and learnings for leadership and management practice too, said Debashis Chatterjee, director, IIM Kozhikode.

Today's ETtech Top 5 newsletter was curated by Erick Massey in New Delhi and Megha Mishra in Mumbai.

Experience your trusted ET newspaper. Now in a brand new way.
The Economic Times print edition. Experience it now with your ET Prime membership.

Read Today's Print Edition
Thanks for reading. We'll be back tomorrow with more interesting stories and updates. Follow us on Twitter and Facebook.

How do you like today's newsletter?

hate it hate it meh meh love it love it

Comments

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side